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effector functions upon arrival will 
also now be of high interest in models 
of acute uremia and in human subjects 
with AKI. 
 In conclusion, these new fi ndings from 
a laboratory with a formidable record in 
the study of leukocyte traffi  cking are both 
exciting and provocative as regards the 
functional status of circulating neutrophils 
during acute uremia and sepsis with AKI. 
It now appears likely that sudden loss of 
renal function is associated with complex 
dysfunction of the normal neutrophil 
responses to injury and infection. Depend-
ing, perhaps, on context, site, and timing, 
the detrimental results may include both 
exaggerated neutrophilic infi ltration of 
peripheral organs and attenuated adhesion 
and transmigration of neutrophils in 
response to endothelial activation. 
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 Mechanistic explanation of the develop-
ment of systemic infl ammatory responses 
across a broad spectrum of non-bacterial 
diseases has emerged with the discovery 
of components of innate immunity 
against pathogenic bacteria — pathogen-
associated molecular patterns and patho-
gen-recognition receptors and one of 
their major components, Toll-like recep-
tors (TLRs) — and with the realization that 
this bacterial defense system can be 
 ‘ hijacked ’ by a host of molecules, alarm-
ins, that are usually released during 
infl ammation. Th is process has been con-
ceptualized by Matzinger as the  ‘ danger 
model. ’ 1 A member of the TLR family, 
TLR4, is especially promiscuous with 
respect to potential ligands and has been 
implicated in the pathogenesis of acute 
kidney injury. 2,3 Th e paper by Christo-
pher Lu ’ s group (Chen  et al. , 4 this issue) 
provides an excellent platform for dis-
cussing the complexity of danger / alarm 
signaling in the kidney. 
 First, the authors examined the course 
of acute kidney injury in two distinct 
strains of mice carrying spontaneous 
disabling  TLR4 mutation (C3H / HeJ and 
C57BL / 10ScNJ) and obtained strong sup-
port for the notion that participation of 
TLR4 is necessary to culminate in 
ischemic renal damage. Th en they asked 
which cell type — radiosensitive leukocytes 
or radioresistant epithelial and endothelial 
cells — is responsible for the TLR4-induced 
kidney damage. To answer this, the inves-
tigators created bone marrow chimeras 
between  TLR4   −  /  −   and  TLR4   +  /  +   mice. 
Ischemic damage was reduced compared 
with that in controls in both cases, that is, 
when bone marrow of irradiated  TLR4   +  /  +  
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mice was reconstituted by  TLR4   −  /  −   trans-
plantation and when bone marrow of 
 TLR4   −  /  −   mice was reconstituted with 
 TLR4   +  /  +   cells. Interestingly, ischemic 
kidney injury was mitigated in both chi-
meras, thus elucidating the necessity of 
TLR4 in leukocytes, as well as in epithelial 
and endothelial cells, for the full-blown 
ischemic response. In my view, this iden-
tifi cation of  ‘ partners in crime ’ is the most 
illuminating fi nding of the paper, with far-
reaching consequences, as discussed 
below. Next, the authors demonstrated 
that  TLR4   +  /  +   leukocytes reside in the 
outer medulla of the  TLR4   −  /  −   irradiated 
recipients of transplanted bone marrow 
and produce proinflammatory inter-
leukin-6 (IL-6) in response to high-mobil-
ity group box 1 (HMGB1) protein 
potentially secreted from damaged epithe-
lial and endothelial cells. A schematic 
summary of this work is presented in  Fig-
ure 1 . It depicts major findings of the 
study of Chen  et al. 4 (in red) on the back-
ground of the broader picture of known 
and potential interactions between 
endothelial and epithelial cells and leuko-
cytes, as well as relevant components of 
the extracellular matrix. 
 Let ’ s look more closely at the main 
players of this triad in the absence of 
exogenous pathogens. TLRs have been a 
subject of several excellent recent 
reviews; thus the reader is referred to 
them. 5 – 7 Th e list of alarmins, endogenous 
signals of tissue damage, is growing and 
includes HMGB1, calgranulins (S100s), 
hepatoma-derived growth factor, heat-
shock proteins, IL-1  , uric acid, thy-
mosins, annexins, galectins, and several 
products released by degranulation of 
neutrophils (defensins, cathelicidins, and 
eosinophil-derived neurotoxin). 8 TLR4, 
in addition to lipopolysaccharide, pepti-
doglycan, and taxol, is activated by 
HMGB1, Tamm – Horsfall glycoprotein, 
hyaluronan, heparan sulfate, fi bronectin 
domain A, surfactant protein A, and 
modifi ed low-density lipoprotein 9 and, in 
the process, is translocated to caveolae. 
HMGB1, an endogenous damage-
 associated molecular pattern molecule, 
resides in the nucleus in a deacetylated 
form but translocates into the cytosol 
and out of the cell when acetylated upon 
stress (reviewed by Tang  et al. 10 ). Export 
 pathways from the cell are incompletely 
understood, though HMGB1 clearly does 
not use classical routes. At least fi ve cog-
nate receptors shared by several alarmins 
exist — TLR2, TLR4, receptor for advanced 
glycosylation end products (RAGE), 
 triggering receptor expressed on myeloid 
cells-1 (TREM1), and CD24 — thus 
 deletion of one of them could prevent sig-
naling from several alarmins. Activation 
of nuclear factor-  B is a downstream 
event of TLR4 ligation that leads to tran-
scriptional induction of proinfl ammatory 
cytokines and chemokines and inter-
feron-inducible genes. Th is system coop-
erates with the activated infl ammasomes 
to trigger  caspase-1-induced cleavage of 
pro-IL-1  and pro-IL-18 and culminate 
in the secretion of these two proinfl am-
matory mediators, IL-1  and IL-18. 
Hence, these are the optimal readout sys-
tems to detect TLR4 activation. 
 The sequence of events proposed by 
Chen  et al. 4 ascribes to the release of 
HMGB1 from damaged epithelial and 
endothelial cells the role of a trigger for 
TLR4-induced activation of leukocytes and 
macrophages, which subsequently secrete 
proinfl ammatory IL-6. Th is scenario, per-
haps, could be expanded in both directions 
on the chronological scale. The initial 
alarm signals in ischemia – reperfusion 
could arise from xanthine  oxidoreductase-
stimulated production of uric acid (in 
minutes) by endothelial and epithelial 
cells, which, via TLR4 and infl ammasome 
activation, leads to the expression of vas-
cular cell adhesion  molecule-1 and inter-
cellular adhesion  molecule-1 on 
endothelial cells and directs the traffi  c of 
leukocytes and monocytes to the pos-
tischemic site. In parallel, the same 
alarmin stimulates the translocation of 
HMGB1 from the nucleus to the cytosol 
to be then exported to the extracellular 
environment. Released HMGB1, in turn, 
reactivates TLR4 and amplifi es its own 
release (M. Rabadi, B. Ratliff , and M.S.G., 
unpublished observations). An additional 
component of this cellular triad is repre-
sented by the extracellular matrix, which 
liberates heparan sulfate and biglycan, 
both of which serve to further stimulate 
TLR4. Activated macrophages produce, 
among other products, nitric oxide and 
thioredoxin, which modulate the redox 
state and the proportion of HMGB1 
present in the reduced and oxidized form. 
Th ese modifi cations of HMGB1 have pro-
foundly different effects on the cells, 10 
ranging from induction of apoptosis to 
autophagy and survival. As plausible as 
this more complicated scenario might be, 






















 Figure 1  |  Interactions between endothelial and epithelial cells and macrophages in the 
course of acute renal ischemia. Pathways proposed by Chen  et al. 4 are highlighted in red. 
See text for details. HMGB1, high-mobility group box 1; ICAM-1, intercellular adhesion molecule-1; 
IL, interleukin; MCP-1, monocyte chemoattractant protein-1; MMPs, matrix metalloproteinases; 
PAI-1, plasminogen activator inhibitor-1; RAGE, receptor for advanced glycosylation end products; 
TLR, Toll-like receptor; TNF-  , tumor necrosis factor-  ; tPA, tissue plasminogen activator; 
UA, uric acid; VCAM-1, vascular cell adhesion molecule-1. 
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other receptors such as TLR2 and RAGE 
and other alarmins  subsequently pro-
duced could hardly be considered as inno-
cent bystanders. Nonetheless, the fact that 
kidney injury can be mitigated by disrup-
tion of TLR4 signaling in any of the 
 members of this cellular triad argues 
strongly in favor of the superiority of this 
pathway over the others. 
 Finally, the question that comes to 
mind is of biological advantages of evolu-
tionary preservation of this system of 
damage-associated molecular patterns 
that seemingly licenses these  ‘ partners in 
crime ’ to cause tissue destruction. Is it just 
a remnant of our defense system against 
exogenous pathogens that has been 
hijacked? Emerging data suggest that this 
same proinfl ammatory system is neces-
sary for the recruitment of stem cells and 
eventual tissue regeneration. 8,10 Learning 
how to inhibit the short-term eff ects while 
preserving the long-term benefits of 
HMGB1 secretion is the challenge facing 
future studies. 
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